Total Unilateral Collapsed Lung- A Sequela of Pulmonary Tuberculosis- and Pregnancy Outcome
Main Article Content
Abstract
Abstract
Lung tissue damage after pulmonary tuberculosis is common and can result in persistent pulmonary disability with negative influence on a patient’s quality of life. On the other hand, a COVID-19 infection in a previously treated tuberculosis patient with residual pulmonary abnormalities imposes an increased risk of death. On their own, both of these diseases can have a devastating effect on a patient’s pulmonary system and as such be the cause of disability or even death. In this case report of total atelectasis of the left lung due to obliteration of the left main bronchus after tuberculosis treatment, we present a pregnant patient, who despite a significant reduction in pulmonary function, managed to have a pregnancy with favorable outcome. Thereafter the patient even recovered from a COVID-19 infection, illustrating resilience of the human body.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Long R, Maycher B, Dhar A, Manfreda J, Hershfield E, Anthonisen N. Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest. 1998;113(4):933-943. doi:10.1378/chest.113.4.933
3. Louis H, Clerf MD. Pulmonary atelectasis in tuberculosis. Chest. 1936;2(12):14-15. doi:10.1378/chest.2.12.14
4. Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA. Lung remodeling in pulmonary tuberculosis. J Infect Dis. 2005;192(7):1201-1209. doi:10.1086/444545
5. Abdelaleem NA, Ahmed MK, Mohamed MN, Bayoumi HA. Lung health after tuberculosis: clinical and functional assessment in post-pulmonary tuberculosis Egyptian patients. Egypt J Bronchol. 2022; 16(23): e1-e6. doi:10.1186/s43168-022-00123-z
6. Daniels KJ, Irusen E, Pharaoh H, Hanekom S. Post-tuberculosis health-related quality of life, lung function and exercise capacity in a cured pulmonary tuberculosis population in the Breede Valley District, South Africa. S Afr J Physiother. 2019;75(1):1319. Published 2019 Jul 31. doi:10.4102/sajp.v75i1.1319
7. Meghji J, Lesosky M, Joekes E, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020;75(3):269-278. doi:10.1136/thoraxjnl-2019-213808
8. Dias AA, de Oliveira DM, Turato ER, de Figueiredo RM. Life experiences of patients who have completed tuberculosis treatment: a qualitative investigation in southeast Brazil. BMC Public Health. 2013;13:595. Published 2013 Jun 19. doi:10.1186/1471-2458-13-595
9. Martínez-Besteiro E, Molina-Molina M, Gaeta AM, et al. Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study. Arch Bronconeumol. 2023;59(4):273-276. doi:10.1016/j.arbres.2023.01.001
10. Lee H, Choi H, Yang B, et al. Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur Respir J. 2021;58(6):2004125. Published 2021 Dec 2. doi:10.1183/13993003.04125-2020
11. Sy KTL, Haw NJL, Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Lond). 2020;52(12):902-907. doi:10.1080/23744235.2020.1806353
12. Global tuberculosis report 2022. World Health Organization; 2022. Accessed September 6, 2023. https://www.who.int/publications/i/item/9789240061729
13. Pasipanodya JG, Miller TL, Vecino M, et al. Pulmonary impairment after tuberculosis. Chest. 2007;131(6):1817-1824. doi:10.1378/chest.06-2949
14. Ravimohan S, Kornfeld H, Weissman D, Bisson GP. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev. 2018;27(147):170077. Published 2018 Feb 28. doi:10.1183/16000617.0077-2017
15. Stek C, Allwood B, Walker NF, Wilkinson RJ, Lynen L, Meintjes G. The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy. Front Microbiol. 2018;9:2603. Published 2018 Oct 30. doi:10.3389/fmicb.2018.02603
16. Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Respiration. 2021;100(8):751-763. doi:10.1159/000512531
17. Almeida de Souza LE, dos Santos Anjos KL, de Sousa DO et al. Atelectasis as a complication of tuberculosis: a case report. International Archives of Medicine. 2018;11(10).
18. Soriano AM, Álvarez LR. Endobronchial Tuberculosis. Tuberculosis endobronquial. Arch Bronconeumol. 2022;58(4):361. doi:10.1016/j.arbres.2021.08.008
19. Watanabe Y, Murakami S, lwa T. Thorac. cardiovasc. Surgeon 36 (1988) 27 32
©Georg Thieme Verlag Stuttgart · New York 20. Madan K, Singh N. Massive compensatory hyperinflation. BMJ Case Rep. 2013;2013:bcr2013008668. Published 2013 Apr 16. doi:10.1136/bcr-2013-008668